Search
taliglucerase alfa (Elelyso)
Indiactions:
- FDA-approved for treatment of Gaucher disease type 1
Dosage:
- intravenous infusion every 2 weeks
Mechanism of action:
- recombinant glucocerebrosidase
Notes:
- first plant-made pharmaceutical to win approval by the FDA
General
recombinant protein; chimer
metabolic agent (metabolic modifier)
References
- Wikipedia: Taliglucerase alfa
http://en.wikipedia.org/wiki/Taliglucerase_alfa
- Taliglucerase Alfa (Intravenous Route)
http://www.mayoclinic.com/health/drug-information/DR603623
- taliglucerase alfa, National Gaucher Foundation
http://www.gaucherdisease.org/protalix_drug_information.php